Why Experts Renamed PCOS: Understanding the Shift to PMOS

Names play an important role in medicine. They shape how conditions are understood, discussed, and even diagnosed. When a name no longer reflects current scientific knowledge, it can create confusion for both patients and healthcare providers. That is why an international group of experts recently proposed renaming polycystic ovary syndrome (PCOS) as polyendocrine metabolic ovarian syndrome (PMOS). While the condition itself has not changed, decades of research have revealed that the condition extends well beyond the ovaries, influencing hormone regulation, metabolism, fertility, and overall health. The updated terminology aims to better reflect this broader understanding and improve patient education, awareness, and care.

Why "Polycystic Ovary Syndrome" Can Be Misleading

For decades, the name "Polycystic Ovary Syndrome" (PCOS) implied that enlarged ovaries, containing numerous small, fluid-filled follicles, were central to the condition. However, many patients have the condition without ever developing ovarian cysts. The emphasis on ovaries in the name conveyed to patients and providers alike that this was primarily a reproductive issue, when in reality, the condition can affect many other aspects of health.

Research suggests that this misnomer has kept 70% of people with the condition from getting a diagnosis. For those who are diagnosed, research has also linked the inaccurate name to delayed, fragmented care and widespread patient dissatisfaction. 

By changing the name to polyendocrine metabolic ovarian syndrome (PMOS), experts hope to close that diagnostic gap, improve patient education, and encourage coordinated, whole-body care. 

PMOS is a Condition That Affects Multiple Body Systems

The new name, polyendocrine metabolic ovarian syndrome (PMOS), reflects how the condition involves several interconnected systems, creating a range of hormonal, metabolic, and reproductive symptoms. Here’s how each system is affected: 

• Endocrine System: The condition involves elevated androgens, often called "male hormones," produced by the ovaries and, in many cases, the adrenal glands. This hormonal shift is what drives symptoms like excess facial or body hair, acne, and hair thinning, in addition to reproductive irregularities. 
• Metabolic System: Insulin resistance is present in the majority of people with the condition. When the body's cells become less responsive to insulin, the pancreas produces more insulin to compensate. Elevated insulin levels can stimulate the ovaries to produce excess androgens. Over time, insulin resistance also increases the risk of developing conditions such as type 2 diabetes, high blood pressure, and cardiovascular disease.
• Reproductive System: The combination of hormonal and metabolic changes tend to disrupt reproductive processes, resulting in irregular or absent ovulation, unpredictable menstrual cycles, difficulty becoming pregnant, and/or the presence of ovarian cysts. 

By recognizing the condition's wide-ranging effects, the proposed name offers a more complete picture of how PMOS influences overall health.

What Does This Mean for Patients?

Patients can expect to see PMOS increasingly used in medical settings, educational resources, and research. However, the proposed name change does not alter how the condition is diagnosed or treated. Healthcare providers will continue to evaluate patients using established diagnostic criteria, which consider factors such as ovulatory dysfunction, elevated androgen levels, elevated anti-Müllerian hormone (AMH) levels, and the presence of polycystic ovaries via ultrasound when appropriate. Likewise, treatment will continue to include lifestyle modifications, medications, or fertility treatments depending on a patient's needs and goals.

Ultimately, the shift to PMOS is intended to provide patients with a more complete understanding of their condition. By recognizing that it extends beyond the ovaries, both providers and patients can take a more comprehensive and proactive approach to care. The name change will also affect how the condition is funded and studied going forward, which experts anticipate will result in better data and, over time, better care and patient satisfaction.

Comprehensive PMOS Care Starts Here

While the proposed name may be new, the importance of comprehensive, patient-centered care has always remained the same. Understanding how PMOS affects your hormones, metabolism, and reproductive health can help you make informed decisions about both your current health and future family-building goals.

At Prelude Fertility, our experienced network of fertility specialists provides personalized evaluations and treatment plans tailored to each patient's unique needs. If you have questions about PMOS, fertility, or your overall reproductive health, we're here to help. Contact us today to learn more.